# New Epilepsy clinical trials: 218 posted since Nov 2024

Updated November 6, 2026.

218 clinical studies in epilepsy were first posted on ClinicalTrials.gov from November 19, 2024 to November 6, 2026; 26 have an industry sponsor and 152 are recruiting or about to. The newest, NCT07923097, was posted on November 6, 2026: Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting... (Rapport Therapeutics Inc.).

## The full list

New Epilepsy clinical trials: 218 rows for $10.90, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 10 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/epilepsy

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 218
- Industry sponsored: 26
- Recruiting or not yet: 152
- Latest posted: November 6, 2026

## Newest trials

The newest 100 of 218, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07923097 | Study Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable. | Rapport Therapeutics Inc. | Phase 1 | Recruiting | Epilepsy | 60 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923097) |
| November 2, 2026 | NCT07909460 | Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis | University College, London | Observational | Not yet recruiting | Epilepsy, Glioma | 56 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909460) |
| October 29, 2026 | NCT07904039 | Characterisation of Laryngeal Evoked Potentials Induced by Vagus Nerve Stimulation in Refractory Epilepsy Patients | Université Catholique de Louvain | Not applicable | Not yet recruiting | Refractory Epilepsy, Epilepsy | 110 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904039) |
| October 29, 2026 | NCT07903168 | Why Do People With Epilepsy Get More Infections? | University of Aberdeen | Observational | Not yet recruiting | Epilepsy, Antiepileptic Drugs, Infection, Immune Dysfunction | 500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903168) |
| October 27, 2026 | NCT07898397 | Long-Term Epilepsy Outcomes in Children With a History of Perinatal Stroke | University Hospital, Strasbourg, France | Observational | Recruiting | Perinatal Stroke, Epilepsy, Post-Stroke Epilepsy | 120 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898397) |
| October 22, 2026 | NCT07888543 | Study of the Link Between Structural Alterations in the Hypothalamus and Cardiac Dysautonomia in Drug-resistant Epilepsy | Centre Hospitalier Universitaire, Amiens | Not applicable | Recruiting | Epilepsy, Hypothalamus, Seizures- Cardiac Dysautonomia, SUDEP | 20 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888543) |
| October 21, 2026 | NCT07885826 | Prospective Longitudinal Study of Sleep, Brain Activity, and Plasma Analyses in Patients Undergoing Epilepsy Surgery | Region Skane | Observational | Not yet recruiting | Epilepsy, Sleep, Drug Resistant Epilepsy, Epilepsy Sleep, Surgery | 40 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885826) |
| October 20, 2026 | NCT07883980 | Antiseizure Medications and CBC in Children With Epilepsy | Assiut University | Observational | Not yet recruiting | Epilepsy | 80 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883980) |
| October 20, 2026 | NCT07883720 | EXercise-induced PhysioLogical Adaptations In Neurological Disorders | Brigham and Women's Hospital | Not applicable | Recruiting | Epilepsy, Functional Neurological Disorder, Mild Cognitive Impairment, Dementia, Parkinson Disease, Concussion, Brain... | 240 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883720) |
| October 19, 2026 | NCT07881185 | Artificial Intelligence for Brain MRI Analysis in Epilepsy | Istituto Giannina Gaslini | Observational | Recruiting | Epilepsies | 2,000 | Australia, Belgium, Brazil, Canada, China, Germany, Italy, Mexico, South... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881185) |
| October 19, 2026 | NCT07879976 | Alexithymia and Emotional Dysregulation in a Cohort of Pediatric Patients With Epilepsy | Istituto Giannina Gaslini | Observational | Recruiting | Alexithymia, Epilepsies | 100 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879976) |
| October 16, 2026 | NCT07877896 | A Device to Prevent Unexpected Death in Epilepsy | Brigham and Women's Hospital | Not applicable | Active not recruiting | Epilepsy | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877896) |
| October 15, 2026 | NCT07876102 | Self-management for Youth With Epilepsy Pilot | University Hospitals Cleveland Medical Center | Not applicable | Not yet recruiting | Epilepsy | 18 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876102) |
| October 8, 2026 | NCT07865546 | Advanced Space-time Resolved Techniques for Functional Neuroimaging at 7 Tesla MRI | Imago 7 Fondazione di Ricerca onlus | Not applicable | Recruiting | Neurological Disorders, Neuroscience, Epilepsy, Brain Injuries, Focal | 180 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865546) |
| October 7, 2026 | NCT07863310 | Effects of Nurse-Led Stigma-Reduction Education in Epilepsy | Muş Alparslan University | Not applicable | Recruiting | Epilepsy | 65 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863310) |
| October 2, 2026 | NCT07854093 | Impact of Epilepsy on Motor Function, Fatigue, and Quality of Life | Borna Farhoomand | Observational | Not yet recruiting | Epilepsy | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854093) |
| September 22, 2026 | NCT07834983 | Time-Domain Heart Rate Variability and QT Interval in Children With Epilepsy | Assiut University | Observational | Not yet recruiting | Epilepsy, Pediatric Epilepsy, Autonomic Dysfunction, Cardiac Arrhythmias | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834983) |
| September 18, 2026 | NCT07828496 | Cognitive Rehabilitation Using Neurofeedback With Brain-computer Interface | KK Women's and Children's Hospital | Not applicable | Recruiting | Acquired Brain Injury Including Stroke, Epilepsy | 70 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828496) |
| September 18, 2026 | NCT07827729 | Aromatherapy and Music on Sleep and Children With Epilepsy | Kafkas University | Not applicable | Completed | Epilepsy | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827729) |
| September 18, 2026 | NCT07827248 | The Effect of a Kolcaba's Comfort Theory-Based Educational Intervention on the Quality of Life of Patients With Epilepsy | Ataturk University | Not applicable | Not yet recruiting | Epilepsy | 80 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827248) |
| September 16, 2026 | NCT07822178 | Neural Mechanisms of Social Attribution From Faces | Cedars-Sinai Medical Center | Not applicable | Enrolling by invitation | Epilepsy Intractable | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822178) |
| September 16, 2026 | NCT07821697 | Translational Recording and Characterization of Epilepsy Signals Using Subgaleal EEG During Standard-of-care SEEG Monitoring | Adraxe Corp. | Early phase 1 | Not yet recruiting | Epilepsy (Treatment Refractory) | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821697) |
| September 4, 2026 | NCT07803692 | High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy... | Oregon Health and Science University | Not applicable | Not yet recruiting | Idiopathic Generalized Epilepsy | 10 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803692) |
| September 1, 2026 | NCT07796984 | Study of the Intracerebral Electrophysiological Signature in the Epileptic Patient | University Hospital, Toulouse | Observational | Not yet recruiting | Epilepsy | 75 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796984) |
| August 27, 2026 | NCT07790224 | Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG Monitoring | Beijing Sanbo Brain Hospital | Not applicable | Not yet recruiting | Epilepsy | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790224) |
| August 20, 2026 | NCT07775976 | Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care... | Peerbridge Health, Inc | Observational | Enrolling by invitation | Cardiovascular Diseases, Cardiovascular Diseases Risk, Cardiac Conduction System Disease, Bundle/Fascicular... | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775976) |
| August 20, 2026 | NCT07775872 | Prospective Natural History Study of POLG Disease | The POLG Foundation | Observational | Recruiting | PolG, Primary Mitochondrial Myopathy | 300 | Australia, Denmark, Finland, Netherlands, Norway, Spain, Sweden, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775872) |
| August 17, 2026 | NCT07768618 | Electrophysiologic Mechanisms of Ketamine Antidepressant Response | Emory University | Phase 2 | Not yet recruiting | Epilepsy, Depressive Symptoms | 37 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768618) |
| August 7, 2026 | NCT07753681 | Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System | Centre for Infectious Disease Research in Zambia | Observational | Recruiting | Cardiac Diseases, Sickle Cell Disease, Hypertension, Diabetes Mellitus, Heart Failure, Congenital Heart Disease... | 2,084 | Zambia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753681) |
| August 6, 2026 | NCT07750496 | Outcomes After Planned Discontinuation of AntiSeizure Medication | University of Michigan | Phase 4 | Recruiting | Epilepsy | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750496) |
| August 3, 2026 | NCT07742709 | Study on the Rapid Diagnostic Value of Sudden Clap Provocation Test in Psychogenic Nonepileptic Seizures | Xijing Hospital | Observational | Active not recruiting | Epilepsy, Psychogenic Non-epileptic Seizures | 1,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742709) |
| July 30, 2026 | NCT07735715 | HOBSCOTCH-YOUTH and Young Adults | Dartmouth-Hitchcock Medical Center | Not applicable | Recruiting | Epilepsy, Cognitive Dysfunction, Cognitive Disorder, Memory and Thinking Problems | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07735715) |
| July 24, 2026 | NCT07725601 | VNS Algorithm for Advanced Dosing | Fernando Vale | Not applicable | Recruiting | Epilepsies | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07725601) |
| July 23, 2026 | NCT07723287 | Risk Factors for Drug-Resistant Epilepsy in Children | Pham Ngoc Thach University of Medicine | Observational | Suspended | Epilepsy, Epilepsy (Treatment Refractory) | 375 | Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07723287) |
| July 23, 2026 | NCT07721272 | Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation | University of Texas Southwestern Medical Center | Early phase 1 | Not yet recruiting | Epilepsy, Essential Tremor, Seizures, Memory Consolidation, Memory Disorders, Memory Replay, Memory Encoding, Cognitive... | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721272) |
| July 21, 2026 | NCT07717632 | AI-enhanced LF-MRI in Epilepsy | University College, London | Not applicable | Active not recruiting | Epilepsy | 39 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717632) |
| July 21, 2026 | NCT07716930 | Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy | Kemal Tutkavul | Observational | Enrolling by invitation | Epilepsy (Treatment Refractory), Epilepsy | 250 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716930) |
| July 20, 2026 | NCT07713706 | Neural Mechanisms for Stopping Ongoing Speech Production (Study 2) | University of Pittsburgh | Not applicable | Enrolling by invitation | Epilepsy, Speech | 12 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713706) |
| July 16, 2026 | NCT07709481 | Epilepsy Enhanced Care | Ente Ospedaliero Cantonale, Bellinzona | Not applicable | Not yet recruiting | Epilepsy | 166 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07709481) |
| July 15, 2026 | NCT07704606 | Metabolites in Blood and Breath in Metabolic Conditions | University Children's Hospital, Zurich | Observational | Not yet recruiting | Inborn Errors of Metabolism, Epilepsy (Treatment Refractory) | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704606) |
| July 10, 2026 | NCT07696442 | Sleep, Music, And Research Trial 2.0 | National Taiwan University Hospital | Not applicable | Recruiting | Epilepsy in Children, Epilepsy | 144 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696442) |
| July 8, 2026 | NCT07689617 | Ultrasound-Guided Intermediate Cervical Plexus Block for Postoperative Analgesia in Vagus Nerve Stimulation Surgery | Firat University | Observational | Completed | Drug-Resistant Epilepsy, Epilepsy, Postoperative Pain | 76 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689617) |
| July 8, 2026 | NCT07689084 | Training Program to Improve EEG Competence | University Hospital Marburg | Not applicable | Completed | Epilepsy, Status Epilepticus, Status Epilepticus, Electrographic, Status Epilepticus, Non-Convulsive, Healthy, Training... | 18 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689084) |
| July 2, 2026 | NCT07680842 | Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy | University of California, San Francisco | Not applicable | Recruiting | Drug-Resistant Epilepsy, Epilepsy, Epilepsy (Treatment Refractory), Epilepsy Comorbidities, Epilepsy, Drug Resistant... | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680842) |
| July 2, 2026 | NCT07680322 | Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1) | Aeovian Pharmaceuticals, Inc. | Phase 2 | Not yet recruiting | Tuberous Sclerosis Complex, Epilepsy | 42 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680322) |
| June 30, 2026 | NCT07676539 | Adapting the STRW Intervention for Adolescents and Young Adults With Epilepsy (ARGOS) | Children's Hospital Medical Center, Cincinnati | Not applicable | Active not recruiting | Epilepsy, Epilepsy in Youth, Activities, Daily Living | 8 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676539) |
| June 25, 2026 | NCT07668856 | Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of... | UMC Utrecht | Phase 3 | Recruiting | Refractory Epilepsy in Children, Refractory Epilepsy, Epilepsy | 50 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668856) |
| June 24, 2026 | NCT07667075 | Role-Playing Method in Epilepsy Teaching Among Nursing Students | Universiti Teknologi Malaysia | Not applicable | Completed | Epilepsy | 135 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667075) |
| June 23, 2026 | NCT07663578 | Cognitive and Electrophysiological Assessment of Non-Invasive Temporally-Interfering Electric Fields Stimulation (TIEFS) | University of California, Davis | Not applicable | Recruiting | Epilepsy | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663578) |
| June 23, 2026 | NCT07663240 | Epilepsy Emergency Department High Utilizer Program | Morehouse School of Medicine | Observational | Enrolling by invitation | Epilepsy, Uncontrolled Seizures | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663240) |
| June 18, 2026 | NCT07657975 | Fluorescence Guided Focal Cortical Dysplasia Surgery | Hospices Civils de Lyon | Phase 2 | Not yet recruiting | Drug Resistant Epilepsy | 5 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07657975) |
| June 16, 2026 | NCT07651709 | Bone Management in Pregnancy Outcomes in Epilepsy | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Not applicable | Recruiting | Epilepsy, Pregnant Woman, Bone Health | 80 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651709) |
| May 26, 2026 | NCT07605858 | Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep | Hospices Civils de Lyon | Observational | Recruiting | Patients With Drug-resistant Focal Epilepsy, SEEG as Part of Presurgical Evaluation | 20 | France, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07605858) |
| May 22, 2026 | NCT07602205 | Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical... | Xuanwu Hospital, Beijing | Not applicable | Not yet recruiting | CDKL5 Deficiency Disorder | 34 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602205) |
| May 20, 2026 | NCT07599150 | Intracranial CArtography of Cortical Contribution to Respiratory Load Compensation in Epilepsy | Hospices Civils de Lyon | Not applicable | Recruiting | Epilepsy, SUDEP | 20 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599150) |
| May 19, 2026 | NCT07595666 | Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. | prof. dr. Koen Van Laere | Not applicable | Enrolling by invitation | Dementia, Movement Disorders, ALS - Amyotrophic Lateral Sclerosis, Epilepsy, Brain Tumors, Pituitary Adenoma, Large... | 1,600 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595666) |
| May 19, 2026 | NCT07594652 | Medication Treatment of ADHD in Pediatric Epilepsy | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Phase 4 | Recruiting | ADHD - Attention Deficit Disorder With Hyperactivity | 25 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594652) |
| May 18, 2026 | NCT07594119 | Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures | Rapport Therapeutics Inc. | Phase 3 | Recruiting | Focal Seizure, Epilepsy, Focal Epilepsy | 312 | Australia, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594119) |
| May 18, 2026 | NCT07592676 | Transition From Pediatric to Adult Care in Epilepsy | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Epilepsy | 64 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592676) |
| May 15, 2026 | NCT07591350 | Assessment of MRI-guided HIFU for Patients With Drug-resistant Focal Epilepsy | Assistance Publique - Hôpitaux de Paris | Not applicable | Not yet recruiting | Epilepsy | 13 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07591350) |
| May 15, 2026 | NCT07588971 | Natural History and Prognosis of Pediatric Epilepsies With Different Etiology | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Pediatric Epilepsies | 2,300 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588971) |
| May 7, 2026 | NCT07572812 | A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy | Shanghai UniXell Biotechnology Co., Ltd | Phase 1 | Recruiting | Epilepsy | 12 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572812) |
| May 6, 2026 | NCT07568860 | Sleep-Driven Adaptive Neuromodulation in Lennox-Gastaut Syndrome | University of Minnesota | Not applicable | Not yet recruiting | Lennox Gastaut Syndrome (LGS), Epilepsy | 4 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07568860) |
| May 4, 2026 | NCT07563881 | Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 | Rapport Therapeutics Inc. | Phase 3 | Recruiting | Focal Seizure, Epilepsy, Focal Epilepsy | 333 | Australia, South Korea, United Kingdom, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563881) |
| April 23, 2026 | NCT07547501 | PREDiction of Different Variants of Sleep Stages for the Diagnosis Support of Chronic Insomnia and Epilepsy | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Chronic Insomnia, Epilepsy, Sleep Disorders | 1,500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07547501) |
| April 22, 2026 | NCT07546253 | Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy | NeuroOne Medical Technologies Corporation | Observational | Recruiting | Drug Resistant Epilepsy, Refractory Epilepsy | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546253) |
| April 22, 2026 | NCT07544563 | Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber | Centre Hospitalier St Anne | Observational | Recruiting | Epilepsy, Anxiety, Depression Anxiety Disorder | 320 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07544563) |
| April 17, 2026 | NCT07537283 | Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy | National Cheng-Kung University Hospital | Not applicable | Completed | Epilepsy, Drugs Resistance | 39 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537283) |
| April 14, 2026 | NCT07527754 | S100B Protein: a Diagnostic Aid in Episodes of Transient Loss of Consciousness? | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Epilepsy, Cryptogenic Epilepsy | 100 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07527754) |
| April 9, 2026 | NCT07520955 | Lily's Grace Temporal Interference | University of Wisconsin, Madison | Not applicable | Not yet recruiting | Epilepsy | 24 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07520955) |
| April 9, 2026 | NCT07519018 | TIS for Drug Resistant TLE | Xijing Hospital | Not applicable | Not yet recruiting | Epilepsy | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07519018) |
| April 3, 2026 | NCT07509190 | Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes | Anny Reyes | Not applicable | Recruiting | Epilepsy | 310 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07509190) |
| April 3, 2026 | NCT07509177 | An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy | Cynthia Kerson | Not applicable | Recruiting | Epilepsy | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07509177) |
| April 2, 2026 | NCT07507240 | The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Treatment: a Pilot... | University Hospital, Toulouse | Not applicable | Not yet recruiting | Epilepsy | 60 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507240) |
| March 27, 2026 | NCT07497178 | MRgFUS for Childhood Epilepsy | The Hospital for Sick Children | Not applicable | Not yet recruiting | Drug Resistant Epilepsy, Epilepsy | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497178) |
| March 24, 2026 | NCT07490769 | Levetiracetam Three Times Daily in Epilepsy | Waad Alkathiri | Phase 3 | Recruiting | Epilepsy | 120 | Saudi Arabia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07490769) |
| March 16, 2026 | NCT07474285 | Cenobamate Efficacy in Individuals With Autoimmune Epilepsy | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Enrolling by invitation | Autoimmune Epilepsy | 30 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07474285) |
| March 13, 2026 | NCT07470931 | Role of High-Frequency Oscillations on Scalp EEG in Identifying Epileptogenic Activity in Patients With Epilepsy and Healthy Controls | Saglik Bilimleri Universitesi | Observational | Completed | Epilepsies | 80 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470931) |
| March 10, 2026 | NCT07460037 | Chinese-Specific Speech Imagery Coding Using High-Density ECoG | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Aphasia, Dysarthria, ALS, Speech and Language Disorder, Stroke, Brain Tumor Adult, Epilepsies, locked-in Syndrome | 50 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07460037) |
| March 6, 2026 | NCT07454785 | Neuronal Mechanisms of Learning and Utilizing Abstract Representations | Cedars-Sinai Medical Center | Not applicable | Enrolling by invitation | Epilepsy Intractable | 114 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454785) |
| March 5, 2026 | NCT07451093 | Epileptiform Potential of Fully Immersive Virtual Reality | Dartmouth-Hitchcock Medical Center | Not applicable | Not yet recruiting | Epilepsy, Seizure | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07451093) |
| March 4, 2026 | NCT07449871 | Psychosocial Burden of Epilepsy | Saglik Bilimleri Universitesi | Observational | Completed | Epilepsy | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07449871) |
| March 4, 2026 | NCT07449845 | Quality of Life Assessment in Patients With Epilepsy Using QOLIE-31 | Saglik Bilimleri Universitesi | Observational | Completed | Epilepsy | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07449845) |
| March 4, 2026 | NCT07448233 | Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas | Xijing Hospital | Not applicable | Enrolling by invitation | Epilepsies, Remote Management of Epilepsy in Rural Areas | 20 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448233) |
| March 3, 2026 | NCT07445074 | AI-Based Mobile Intervention on Medication Non-Adherence and Transition | University of Central Florida | Not applicable | Recruiting | Epilepsy, Seizure | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445074) |
| February 27, 2026 | NCT07434986 | Overnight TI in TLE | Duke University | Not applicable | Recruiting | Temporal Lobe Epilepsy (TLE), Drug Resistant Epilepsy, Sleep | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07434986) |
| February 19, 2026 | NCT07422233 | Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults | Nasim Tabrizi | Phase 4 | Completed | Epilepsy, Elderly | 137 | Iran | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422233) |
| February 19, 2026 | NCT07421661 | Effect of Epilepsy and Antiepileptic Drug Therapy on Gastric Motility and Emptying With Point-Of-Care Gastric Ultrasound | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Observational | Not yet recruiting | Epilepsy | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421661) |
| February 18, 2026 | NCT07417280 | LIFUS For Neurological Disorders | University Health Network, Toronto | Not applicable | Recruiting | Parkinson's Disease (PD), Essential Tremor, Orthostatic Tremor, Dystonia, Epilepsy, Substance Abuse Disorder, Deep... | 50 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07417280) |
| February 3, 2026 | NCT07385157 | Ultra-long-term EEG Monitoring in PwID | University of Plymouth | Observational | Active not recruiting | Epilepsy, Intellectual Disability, Mild to Moderate | 9 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385157) |
| January 30, 2026 | NCT07378397 | OPM MEG in Pre-surgical Mapping for Patients With Epilepsy | Aston University | Observational | Enrolling by invitation | Epilepsy (Treatment Refractory), Epilepsy in Children, Epilepsy in Youth | 20 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07378397) |
| January 29, 2026 | NCT07377032 | TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders | Meyer Children's Hospital IRCCS | Phase 3 | Recruiting | GRIN-related Disorders, GRIN1, GRIN2A, GRIN2B, GRIN2D, Epilepsy, Neurodevelopmental Disorder (Diagnosis) | 40 | France, Italy, Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07377032) |
| January 28, 2026 | NCT07373431 | Biomarkers for Epilepsy Development and the Effect of Physical Exercise in Children With Autism | Region Skane | Not applicable | Completed | Epilepsy, Autism Spectrum Disorder | 50 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373431) |
| January 23, 2026 | NCT07363603 | Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. | Pirogov Russian National Research Medical University | Phase 1/2 | Recruiting | GNAO1, Epilepsy, Hyperkinesis | 5 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363603) |
| January 21, 2026 | NCT07356661 | Evaluation of the Efficacy of Neurofeedback Technique Based on EEG Desynchronization in Epileptic Patients | Assistance Publique Hopitaux De Marseille | Not applicable | Not yet recruiting | Epilepsy, Drug Resistant Epilepsy | 22 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07356661) |
| January 21, 2026 | NCT07353918 | Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy | Carilion Clinic | Not applicable | Enrolling by invitation | Epilepsy (Treatment Refractory), Epilepsy Comorbidities | 6 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07353918) |
| January 20, 2026 | NCT07350551 | Pediatric Epilepsy | University of Texas Southwestern Medical Center | Not applicable | Recruiting | Epilepsy Intractable | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07350551) |
| January 15, 2026 | NCT07342296 | Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38 | Danish Headache Center | Not applicable | Not yet recruiting | Migraine With Aura, Migraine Aura | 21 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07342296) |
| January 9, 2026 | NCT07329257 | Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) | University of Missouri-Columbia | Observational | Recruiting | Baker Gordon Syndrome, Rare Neurodevelopmental Conditions, Rare Neurogenetic Conditions, Syt-1 Disorder, Epilepsy... | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07329257) |
| January 5, 2026 | NCT07316972 | CEST-based Biomarkers to Delineate the Epileptogenic Zone | Fondation Ophtalmologique Adolphe de Rothschild | Not applicable | Not yet recruiting | Epilepsy (Treatment Refractory) | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07316972) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Hospices Civils de Lyon | 7 | June 18, 2026 |
| Assistance Publique - Hôpitaux de Paris | 6 | May 15, 2026 |
| Assiut University | 5 | October 20, 2026 |
| Rapport Therapeutics Inc. | 4 | November 6, 2026 |
| Xijing Hospital | 4 | August 3, 2026 |
| Fondation Ophtalmologique Adolphe de Rothschild | 4 | January 5, 2026 |
| University College, London | 3 | November 2, 2026 |
| University of Texas Southwestern Medical Center | 3 | July 23, 2026 |
| Xuanwu Hospital, Beijing | 3 | May 22, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 | May 18, 2026 |
| Saglik Bilimleri Universitesi | 3 | March 13, 2026 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 | March 10, 2026 |
| Praxis Precision Medicines | 3 | December 17, 2025 |
| IRCCS National Neurological Institute "C. Mondino" Foundation | 3 | February 7, 2025 |
| Region Skane | 2 | October 21, 2026 |
| Brigham and Women's Hospital | 2 | October 20, 2026 |
| Istituto Giannina Gaslini | 2 | October 19, 2026 |
| Muş Alparslan University | 2 | October 7, 2026 |
| Kafkas University | 2 | September 18, 2026 |
| Ataturk University | 2 | September 18, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 99 | October 29, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 79 | November 2, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 12 | June 25, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 10 | November 6, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 7 | August 6, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 6 | September 16, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 4 | August 17, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 1 | January 23, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 68 | October 20, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 28 | October 27, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 21 | October 19, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 19 | October 19, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 17 | October 7, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 12 | October 19, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 9 | October 19, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 8 | November 6, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 7 | October 19, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 7 | October 19, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 7 | October 19, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 6 | October 21, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 5 | August 20, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 4 | October 19, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 4 | October 19, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 4 | July 10, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 4 | December 17, 2025 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 3 | October 19, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 2 | August 20, 2026 |
| [Norway](https://specstream.ai/data/clinical-trials/country/norway) | 2 | August 20, 2026 |
| [Iran](https://specstream.ai/data/clinical-trials/country/iran) | 2 | February 19, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 2 | January 29, 2026 |
| [Bangladesh](https://specstream.ai/data/clinical-trials/country/bangladesh) | 2 | July 31, 2025 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 2 | April 3, 2025 |
| [Latvia](https://specstream.ai/data/clinical-trials/country/latvia) | 2 | April 3, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).